Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00338312 · ClinicalTrials.gov registry record · Phase 3
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
A Phase 3 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 3
- Development phase
- 610
- Enrollment target
NCT00338312 is a Phase 3 study that has completed, run by Warner Chilcott. The registered enrollment target is 610 participants.
The verdict
NCT00338312, a Phase 3 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 610 participants
- Enrollment target
Study Summary
This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogen/progestin therapy.
Interventions
- DRUG Placebo patch
- DRUG Testosterone Transdermal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 610 participants |
| Start Date | 2002-06 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00338312
The ClinicalTrials.gov registry entry for NCT00338312 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 610 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo patch is the first listed.
NCT00338312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00338312 about?
NCT00338312 is a clinical study titled "Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido". This study is designed to evaluate efficacy and safety of a testosterone patch as treatment for low libido in naturally menopausal women who are taking estrogen or estrogen/progestin therapy.
What is the current status of trial NCT00338312?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 610 participants. The study started on 2002-06. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00338312?
The interventions under investigation include: Placebo patch (DRUG), Testosterone Transdermal System (DRUG).
Who is sponsoring clinical trial NCT00338312?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.